24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publication dates

Stem Cell Industry, November 2014 Market Reports from Top Publishers

You might be interested in: Medical Equipment, Therapeutics, Cancer, more »


 
1-10 of about 200 reports for Stem Cell

BIONET Corp. (Symbol:1784) SWOT Analysis, Strategy, Revenues and Profits

BIONET Corp. (Symbol:1784) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Diagnosis, genesis-24 pre-implantation genetic screening services, down syndrome screening methods, spinal muscular atrophy genetic testing, dental pulp stem cell storage service, and preventive genetic ...

MediPost Co., Ltd. (Symbol:078160) SWOT Analysis, Strategy, Revenues and Profits

MediPost Co., Ltd. (Symbol:078160) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Cord blood derived mesenchymal stem cells (hucb-mscs). The company markets products through brands such as cartistem, neurostem, pneumostem and promostem. It collaborates with sungkyunkwan university ...

Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Cord tissue stem cells, and bloodstor. The company caters to regenerative medicine, biobanking, and drug discovery markets. Biolife solutions is headquartered in bothell, washington, the us ...

GENova Biotherapeutics, Inc. (Symbol:GVBP) SWOT Analysis, Strategy, Revenues and Profits

GENova Biotherapeutics, Inc. (Symbol:GVBP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... The company's stem cell technology is a two-way approach including a method to identify specific biomarkers for breast cancer cells and various methods to destroy these malignancies. Genova is headquartered ...

International Stem Cell Corporation (Symbol:ISCO) SWOT Analysis, Strategy, Revenues and Profits

International Stem Cell Corporation (Symbol:ISCO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... S products include stem cells, parthenogenesis, and therapeutic programs. Iscc provides stem cells such as embryonic stem cells, induced pluripotent stem cells, adult stem cells and parthenogenetic stem cells ...

Optimer Pharmaceuticals, Inc. (Symbol:OPTR) SWOT Analysis, Strategy, Revenues and Profits

Optimer Pharmaceuticals, Inc. (Symbol:OPTR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... For the treatment cdad prophylaxis in hematopoietic stem cell transplantation (hsct) patients, cdad in pediatric patients, and cdad multiple recurrence; and dificlir and fidaxomicin for the treatment of clostridium ...

Protokinetix Inc. (Symbol:PKTX) SWOT Analysis, Strategy, Revenues and Profits

Protokinetix Inc. (Symbol:PKTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Survival and health. Its anti-aging glycopeptides are used to protect cell lines, such as hela cells, adult fibroblast, neonatal fibroblasts, human neuronal stem cells, mouse neuronal stem cells, mouse islet ...

CHA Bio & Diostech Co., Ltd. (Symbol:085660) SWOT Analysis, Strategy, Revenues and Profits

CHA Bio & Diostech Co., Ltd. (Symbol:085660) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Cameras and mobile phones. The company provides services such as bio cosmetics, bio insurance, stem cell technologies and therapeutics, and medical cell therapy, among others. It serves biological ...

Mesoblast Limited (MSB) - Financial and Strategic SWOT Analysis Review

Mesoblast Limited (MSB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... cells (dpscs) and hematopoietic stem cells (hscs). Mesoblast serves various therapeutic areas such as immunologic/ inflammatory, cardiac vascular, spine disease, ophthalmolog, neurologic and oncology ...

StemCells, Inc. (STEM) - Financial and Strategic SWOT Analysis Review

StemCells, Inc. (STEM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Note*: some sections may be missing if data is unavailable for the company list of tables stemcells, inc., Key information stemcells, inc., Key ratios ...

About 1 300 reports for Stem Cell

Download Unlimited Documents from Trusted Public Sources

Stem Cell Industry in Russia

  • The Social Legitimation of Biomedical Technologies in Russia Co
  • January 2013
    21 pages
  • Stem Cell  

  • Russian Federat  

View report >

Annual Report 2014

January 2014

3 Companies for Stem Cell

Read our Company Profiles

Athersys Inc.

United States

Bioheart Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.